Oral contraceptives and malignant hepatoma.
D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced*; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000139:chemically induced*; D008234:Lynestrenol / Q000009:adverse effects*; D008656:Mestranol / Q000009:adverse effects*
D003276:Contraceptives, Oral; D004338:Drug Combinations; D008656:Mestranol; D008234:Lynestrenol